RxDoctor Payments Data

Samuel Hathcock, PA

Physician Assistant · Gainesville, FLNPI 1992375554

Payments from drug & device makers

$1,744in general payments, 2019–2025

Across 60 payments — averaging $29.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$299
  • E.r. Squibb & Sons, L.L.C.$227
  • Kestra Medical Technology Services, Inc.$211
  • Merck$158
  • Amgen$143
  • Limflow Inc.$135
  • plus $572 from 11 others

What the payments were for

  • Food & beverage$1,744100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,744 in reported general payments places this provider in the 70th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$23,912
Medicare patients
198
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban130$117,589
EntrestoSacubitril/Valsartan44$44,467
JardianceEmpagliflozin56$39,712
XareltoRivaroxaban39$32,892
Repatha SureclickEvolocumab32$26,492
Metoprolol Succinate88$1,322
Atorvastatin Calcium114$1,045
Valsartan20$614
Rosuvastatin Calcium36$612
Diltiazem 24hr Er (Cd)Diltiazem Hcl13$464
ClopidogrelClopidogrel Bisulfate37$455
Ezetimibe24$424
Losartan Potassium47$414
Amiodarone Hcl21$350
Amlodipine Besylate68$274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$60$117,589130 claims
NovartisEntresto$37$44,46744 claims
Boehringer IngelheimJardiance$95$39,71256 claims
Johnson & JohnsonXarelto$36$32,89239 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →